1. Home
  2. WTO vs MRKR Comparison

WTO vs MRKR Comparison

Compare WTO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTO
  • MRKR
  • Stock Information
  • Founded
  • WTO 2008
  • MRKR N/A
  • Country
  • WTO China
  • MRKR United States
  • Employees
  • WTO N/A
  • MRKR N/A
  • Industry
  • WTO Consumer Electronics/Appliances
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WTO Technology
  • MRKR Health Care
  • Exchange
  • WTO Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • WTO 12.6M
  • MRKR 11.6M
  • IPO Year
  • WTO 2021
  • MRKR N/A
  • Fundamental
  • Price
  • WTO $1.34
  • MRKR $0.95
  • Analyst Decision
  • WTO
  • MRKR Strong Buy
  • Analyst Count
  • WTO 0
  • MRKR 3
  • Target Price
  • WTO N/A
  • MRKR $13.17
  • AVG Volume (30 Days)
  • WTO 519.6K
  • MRKR 2.7M
  • Earning Date
  • WTO 09-23-2025
  • MRKR 08-14-2025
  • Dividend Yield
  • WTO N/A
  • MRKR N/A
  • EPS Growth
  • WTO N/A
  • MRKR N/A
  • EPS
  • WTO N/A
  • MRKR N/A
  • Revenue
  • WTO $34,589,265.00
  • MRKR $5,388,071.00
  • Revenue This Year
  • WTO N/A
  • MRKR N/A
  • Revenue Next Year
  • WTO N/A
  • MRKR $15.82
  • P/E Ratio
  • WTO N/A
  • MRKR N/A
  • Revenue Growth
  • WTO 54.01
  • MRKR 44.55
  • 52 Week Low
  • WTO $0.75
  • MRKR $0.81
  • 52 Week High
  • WTO $8.56
  • MRKR $5.95
  • Technical
  • Relative Strength Index (RSI)
  • WTO 68.75
  • MRKR 41.16
  • Support Level
  • WTO $1.03
  • MRKR $0.83
  • Resistance Level
  • WTO $1.40
  • MRKR $1.02
  • Average True Range (ATR)
  • WTO 0.12
  • MRKR 0.09
  • MACD
  • WTO 0.05
  • MRKR 0.01
  • Stochastic Oscillator
  • WTO 70.76
  • MRKR 24.51

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: